In the Department of Veterans Affairs cooperative study of amiodarone in congestive heart failure , 674 patients with New York Heart Association class II through IV symptoms and ejection fractions of < or = 40 % were treated with amiodarone or placebo for a median of 45 months in a randomized , double-blind , placebo-controlled protocol .
